In the present study, we recruited a thalassemia patient with β41-42 (TCTT) deletions in the human β-globin (HBB) gene and a Hb-WS mutation (ααWS/αα) in the human hemoglobin alpha 2 (HBA2) gene. This evidence concerns the gene HBA2 and thalassemia.